Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all

E-ISSN： 1365-2710|43|1|159-162

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.43, Iss.1, 2018-02, pp. : 159-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pimecrolimus for the treatment of atopic dermatitis

By Breuer Kristine Werfel Thomas T Kapp Alexander

Therapy, Vol. 2, Iss. 1, 2005-01 ,pp. : 37-56

Future Medicine

Access to resources Recommend Favorite

Pranlukast, a Leukotriene Receptor Antagonist, Inhibits Interleukin-5 Production via a Mechanism Distinct from Leukotriene Receptor Antagonism

International Archives of Allergy and Immunology, Vol. 136, Iss. 2, 2005-02 ,pp. : 165-172

Karger

Access to resources Recommend Favorite

In situ Expression of Interleukin-12 Is Markedly Inhibited after Treatment with Topical Corticosteroids in Chronic Atopic Dermatitis

International Archives of Allergy and Immunology, Vol. 124, Iss. 1-3, 2012-01 ,pp. : 377-379

Karger

Access to resources Recommend Favorite

Atopic dermatitis: a review of topical treatment options

By Simpson Eric L.

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 633-640

Informa Healthcare

Access to resources Recommend Favorite

Repetitive Immunoadsorption Cycles for Treatment of Severe Atopic Dermatitis

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 3, 2015-06 ,pp. : 279-287

John Wiley & Sons Inc

Access to resources Recommend Favorite